Medical Tender &
Business Talk

Dr. Fatima Zaid Abu Zanat is an aspirational and experienced Regulatory Affairs/Quality Assurance (RA/ QA) professional with total of 17 years’ experience, with more than 12 RA/QA years in medical device, pharmaceutical and biotech industry across emerging markets with solid scientific background in product research/ development. She holds RAPS Dual Regulatory Affairs Diploma and Certificate (RAC Dual) in Medical Devices/Pharmaceuticals in addition to MSc in Pharmaceutical Technology. She is an active member in regulatory working groups within regulatory associations such as RAPS MENA local networking group as well as industry associations such as PhRMA MEA and formerly MECOMED. She is a licensed Basic Life Support Giver by American Heart Association and Licensed Specialist Pharmacist by UAE Ministry of Health and Jordan Food and Drug Administration.

She successfully established and managed multiple, UAE Scientific Offices for regional headquarters of emerging markets within Dubai, UAE; enabling organic/in-organic business growth. She built strong, direct channels with key, regional health authorities for continuous, shaping of the industry. She is experienced with development and management of teams on regional/global levels.

International publications:

• RAPS E-BOOK: F.Z. ABU– ZANAT(2022). Section IV postauthorization commitments and studies: Chapter 18 Middle East and North Africa. In L.M. and P.T (Ed.). Postapproval Changes for Drugs: A Practical Guide (pp. 209 – 212). RAPS.
• RP– LC Analysis Article: F.Z. ABU– ZANAT(2012). Ibuprofen Determination in Aqueous Solutions and Biological Samples. MedLab Magazine, 2012 (1): 36 – 42.
• Research Article: F.Z. ABU– ZANAT et al(2011). A Promising Codrug of Nicotinic Acid and Ibuprofen for Managing Dyslipidemia. I: Synthesis and In Vitro Evaluation. Drug Development and Industrial Pharmacy, 37 (9): 1090 – 1099.

Honors and awards:

• Women of Ipsen Nomination – 2022: One of 68 nominated Women of Ipsen for 2022 and the only one from META region.
• DUPHAT 2012 – 3rd Best Professional Poster Award: Professional Poster and Oral Presentation entitled “Synthesis and Evaluation of Nicotinic Acid and Ibuprofen Codrug for Managing Dyslipidemia by Newly Developed and Validated HPLC Method”, based on MSc Pharmaceutical Technology thesis dissertation.

I am seasoned professional with 16 years of experience working in multinational companies across various functions. I am graduated from Cairo University’s Pharmacy College and have since built a career around market access and helping authorities find innovative, sustainable solutions to increase medication accessibility for patients.

I have furthered your education by earning a certificate degree in Healthcare Economics from Harvard University and are currently pursuing a master’s in public health.

Through your work and studies, I have demonstrated a deep commitment to improving the health outcomes of communities in my region. My passion for this work is evident in everything I do, and I am constantly seeking new ways to innovate and make a positive impact on people’s lives.

He has worked in ministry of health and population as governmental inspector for health care institutions since 2017. Dr. Mohamed worked in Baheya institute for breast cancer as the procurement director . Also, he worked in many hospitals as El Hekma , El Salam international hospital as well as some outpatient pharmacies .

He’s from the board that governs the use of the scientific treatment protocol for COVID -19 MOHP.

Also participated in the tender with UPA for the governmental sector concerned with medical supplies, pharmaceutical products in health care industry.

• Graduated from faculty of pharmacy, Cairo University 2012 .
• Harvard leadership development program certified.
• ISCEA training diploma for CSCA , ongoing CSCM.
• USAID program certified, also syreon research institute  Health economics & Pharmacoeconomics diploma .
• Decision making & strategic planning diploma from Nasr academy.
• Critical appraisal and full economic Analysis certificate from GLSBOR .
• Riti’s institute supply chain management diploma.

Dr. Sara Al Dallal, the president of the Emirates Medical Association’s Emirates health Economics Society and a specialist in Dubai Health Authority. Dr Sara is a Medical Doctor graduated from the UAE University College of Medicine and Health Sciences. She completed her internal medicine residency in Dubai Health Authority and holds a Masters in Health Care Management from Royal Colleges of Surgeons Ireland and Masters in Health Economics and policy from London School of Economics.

Shereen Abdalla is a seasoned professional in the innovative pharmaceutical industry with over 15 years of experience in sales, marketing, market access & government affairs in the Middle East region. Currently, she serves as the Director of Communications, Government Affairs, and Market Access at GSK for the Gulf Region.

Shereen holds a bachelor’s degree in Pharmaceutical Science from Al Israa Jordan University and Master’s degrees in Health Economics and Pharmacoeconomics from Barcelona University. Her areas of focus include access to innovative medicines and vaccines, health economics, value-based healthcare systems, and healthcare policies.

Throughout her career, Shereen has been dedicated to advancing healthcare in the Gulf region and ensuring that patients have access to the latest treatments and vaccines. With her extensive knowledge and experience in the pharmaceutical industry, she has been instrumental in promoting healthcare initiatives and shaping healthcare policies in the region.

As the Director of Communications, Government Affairs, and Market Access at GSK, Shereen is committed to working with government authorities, healthcare organizations, and other stakeholders to improve access to innovative medicines and vaccines in the Gulf Region.

With her passion for improving healthcare outcomes and her strong commitment to her work, Shereen is poised to make a lasting impact on the health and well-being of people in the Gulf region.

Sumaya is a pharmacist who is very passionate in helping the growth of the Healthcare Industry in her home country, Iraq.

Driven by her ambition in providing the most innovative products, she always creates the right roadmap to secure the access and availability of medications to Iraqi patients. With more than 13 years of experience, Sumaya has mastered an outstanding skill in managing MoH tenders and finding alternative solutions, amid the most challenging situations. She believes that Agility and Adaptability are the secret recipe for success, especially in this part of the world.

When she is not working, you will find Sumaya swaying to the tunes of Latin music, which is another passion in her life.

She is a committed professional with exceptional administrative skills and operational experience who develops best practice and leads transformational change.

Significant exposure in working on strategic management, organizational development, conducting organizational assessments, performance management and process engineering/re-engineering.

Adopt at working under tight deadlines and delivering results under demanding work conditions. Efficient Team Leader & Player.

Abdalla Aboutaleb is one of the most profound experts in healthcare policy and regulations in the MENA region. His expertise extends from HTA & Reimbursement policies to regulatory and supply chain strategies in the public sector. He has been involved in the fields of health economics, outcomes research, health policy reforming and

Reimbursement police within the healthcare industry for 15 years, with experience across the pharmaceutical, biologicals and vaccines. And now works for WHO as a project manager at health care reforming area. He, in addition to being a committee member and project manager in a number of national projects in many countries

including Germany. United Kingdom, Egypt, Algeria, Sudan, Russia, UAE, Morocco, Jordan, Iraq, Turkey, KSA, GULF, USA and Poland. He is a very active researcher with tens of publication across different well recognized organizing including ISPOR, ESMO, ASCO , ECCO, iHEA.

HTAI and EuHEA. He has been a true contributor to several public and industrial projects in Egypt and the MENA region of his homeland. He committedly changed the landscape of the healthcare policy there. A few examples to mention are his contributions to the establishment of the NORCB (national organization for control and research of biologics), Egyptian Biosimilars guidelines the

cancer and MS registry & guidelines. Establishing stroke units & guidelines, hospital based HTA and Health economic unit at the Ministry of Health in Egypt’s different sectors.

Multiple engagement efforts are well recognized in his research through introducing concepts of stakeholder engagement. He also does that by being an active member of many research organizations internationally and locally like the ISPOR and its local chapter. Abdalla Aboutaleb remains a very rich source of developmental initiatives having been hands on expert across different sectors of the healthcare systems and a visionary for healthcare reform.

Senior-level executive with 20+ years of Middle East experience. Maximizes results by leveraging multi-channel effective communication, setting and implementing best strategies and tactics practices, remaining receptive to change and the ideas of others, and introducing new offerings and innovations to new and presently existing processes, while bringing passion to purpose and people. Consistently delivers successful outcomes during times of crisis or uncertainty, within the most challenging environments.

Serves as a trusted advisor and confidante to peers, executives, organizational partners, and multi-cultural and multidisciplinary teams. Inspires the identification of hidden opportunities and the development of innovative solutions by collaborating with key stakeholders. Leads through honesty, integrity, and teamwork.

Mr. John Mikhail, has more than 20 years’ experience in the pharmaceutical industry working in MSD across different commercial functions in Egypt and GCC (sales, marketing, Key Account manager, Tender manager) Also, across various therapy areas including Oncology, Hospital Acute Care, Diabetes, Vaccines and Primary Care.

John’s focus on Strategic Pricing across Gulf started in 2013 where he witnessed the evolving pricing dynamics in GCC starting from GCC price unification implementation throughout the evolving International Price Referencing ending with the new pricing guidelines in Kuwait recently in early 2021.

John’s strong analytical skills can address complex pricing challenges and identify Pricing opportunities.

John’s effective communication skills helped him in multiple negotiations with different
stakeholders across the Gulf.

M Amin has more than 25 years of experience in the pharmaceutical industry; Started his career in BMS, Then Joined Astrazeneca in 2008 as Sales Manager in Oncology & CNS Business Unit, then appointed as Head of Market Access in 2014, and currently holding the role of Director of Governmental Affairs, Market Access for advocating AstraZeneca the government partnership agenda and impact in Egypt Healthcare ecosystem.

He has several publications in prominent Health economics Journals and has been an invited speaker in many workshops and panel discussions in Health economics and Health Policy.

M Amin serves in Egypt PHRMA Group as the lead for access to innovation working group

He holds a Health Economic diploma & several professional certificates   in Health economics & Outcome research from different international reputable entities

Nico has spent over 13 years in the pharmaceutical industry in local, regional and global roles. He has built and led the global team at Pfizer responsible for the management of the worldwide Tender & Contracting business and the continuous improvement of tender processes, tools, capabilities and policies. During this time he was also part of Pfizer’s global x-functional leadership team for Biosimilars. Nico is one of the few people who have personally built and lead a truly global and x-functionally aligned tender organization in big pharma.

He has nearly two decades of experience working across the healthcare ecosystem. Prior to Vamstar, Praful was a Senior Partner for IHS Markit and developed healthcare industry’s data and market access capability.

Throughout his career, he has developed solutions pertaining to market access, procurement, pricing and reimbursement, supply chain, and tendering of pharmaceuticals, medical devices, and diagnostics.

Mr. Praful has been a long-time advisor to senior teams across the ecosystem on issues of market access strategies, procurement excellence, launch planning, market competitiveness, and commercialisation strategies. He has significant project experience in working with the BRIC-MT, MENA, APAC, and EU-30 nations, as well as the United States and Japan.

Mr. Praful has been interviewed and quoted in many different journals, print media, blogs, and leadership forums during the two-decades long tenure.

Dr. Yasser Hosny, Senior Manager Market Access at Gulf Pharmaceutical Industries Manufacturers Julphar, has more than 28 years of an extensive experience in market access, tender management, and business development in the Middle East, Africa, Europe, and Asia regions. before joining Julphar in 2020, he was responsible for Market access, tender management, and health economics for the EMEA region at Johnson and Johnson diabetes care companies for more than 5 years.

Ms. Maya Chehayeb works in pharmaceutical industry for more than 20 years where she gained a wide experience by assuming different roles and responsibilities.

She currently holds the position of Commercial Excellence Lead at Biologix FZCO, leading and overseeing company centralized operations in the Middle East & North Africa while heading 3 entities.

Those operations include but are not limited to demand planning, tender management, sales performance assessment, financial reconciliation support, FOC & expired goods management, pricing operations, sub-distributors governance, market mapping database & analytics, Sales & Marketing effectiveness & other projects.

She is responsible for setting & executing strategies and programs to increase efficiency in operations and to minimize risks’ implications.

Maya has joined the Company in 2003 and started her career as medical representative in the Sales department and then was promoted to Senior Brand Manager & Senior Group Brand Manager heading Marketing for a wide range of products. She has as well a solid experience in multichannel communications including events management, promotion & advertising and digital marketing implementation.

She succeeded in developing a set of processes & tools at different levels to optimize cross-functional integration in different operations. She is also a certified internal trainer, and she worked hard through her career to prepare many workshops supporting in skills and capability building.

She holds a Master in Biochemistry from the Lebanese University- Faculty of Sciences. She is also talented in painting and enjoys cooking.